FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer

ABSTRACT: In this trial chemotherapy regimen FOLFOX with intrahepatic administration of oxaliplatin is combined with immunotherapy (nivolumab and ipilimumab) for the group of patients with multiple liver metastasis from colorectal cancer. Investigators hope to increase the disease-free survival after 3 years from 10 % to 30%.

DISEASE(S): Liver Metastasis From Colorectal Cancer,Metastatic Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms

PROVIDER: 2342502 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR